Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Hua-Xiang Wu"'
Autor:
Qiong Fu, Ping Feng, Ling-Yun Sun, Xiao-Xia Zuo, Dong-Bao Zhao, Dong-Yi He, Hua-Xiang Wu, Wei Zhang, Fang Du, Chun-De Bao, Li-Shao Guo.
Publikováno v:
Chinese Medical Journal, Vol 134, Iss 12, Pp 1457-1464 (2021)
Abstract. Background:. Clinical observational studies revealed that 99Tc-methylene diphosphonate (99Tc-MDP) could reduce joint pain and swollenness in rheumatoid arthritis (RA) patients. This multicenter, randomized, double-blind, double-dummy study
Externí odkaz:
https://doaj.org/article/d0154d708632476ea9faff729426fb6b
Autor:
Chun Li, Yan Zhang, Hui Song, Jie Gao, Dong-Bao Zhao, Qi Zhu, Dong-Yi He, Li Wang, Xiang-Pei Li, Xu-Dong Liu, Wei-Guo Xiao, Xin-Yu Wu, Hua-Xiang Wu, Wei Tu, Shao-Xian Hu, Xin Wang, Zhi-Jun Li, Zhi-Min Lu, Zhan-Yun Da, Bo Liang, Xiao-Min Liu, Jin-Wei Zhao, Ling Li, Feng Han, Wu-Fang Qi, Wei Wei, Xu Ma, Zhen-Bin Li, Gui-Min Zheng, Feng-Xiao Zhang, Yi Li, You-Lian Wang, Guang-Hui Ling, Jin-Wei Chen, Xiao-Qiang Hou, Jing Zhang, Qing-Ping Chen, Chang-Lian Liu, Jia-Shun Zeng, Qing-Hua Zou, Yong-Fei Fang, Yin Su, Zhan-Guo Li, Ning-Ning Wang
Publikováno v:
Chinese Medical Journal, Vol 132, Iss 24, Pp 2899-2904 (2019)
Abstract. Background:. Clinical outcomes of undifferentiated arthritis (UA) are diverse, and only 40% of patients with UA develop rheumatoid arthritis (RA) after 3 years. Discovering predictive markers at disease onset for further intervention is cri
Externí odkaz:
https://doaj.org/article/bc614877ac85409abb0537569e212fcb
Autor:
Wen Qin, Li Zhou, Ting-Hui Wang, Han Cen, Xiu-Di Wu, Hua Huang, Bin-Hua Xie, Hua-Xiang Wu, Dong-Mei Xiao
Publikováno v:
Archives of Rheumatology. 34:406-413
Objectives This study aims to determine whether baseline body mass index (BMI) affects clinical response to tocilizumab (TCZ) after six months of treatment in rheumatoid arthritis (RA) patients. Patients and methods In this prospective study, a total
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::482e0b3b9057fde135e4a63d42cd4760
https://doi.org/10.5606/archrheumatol.2019.7146
https://doi.org/10.5606/archrheumatol.2019.7146
Autor:
Dan Shi, Jie-Yu Chen, Hua-Xiang Wu, Qi-Jing Zhou, Hai-Yan Chen, Yuan-Fei Lu, Ri-Sheng Yu, Shi, Dan, Chen, Jie-Yu, Wu, Hua-Xiang, Zhou, Qi-Jing, Chen, Hai-Yan, Lu, Yuan-Fei, Yu, Ri-Sheng
Publikováno v:
Medicine; 12/20/2019, Vol. 98 Issue 51, p1-9, 9p
Publikováno v:
Clinical Chemistry and Laboratory Medicine (CCLM). 57:1668-1679
Background Previous reviews of the diagnosis for rheumatoid arthritis (RA) have not compared anti-mutated citrullinated vimentin (MCV) with anti-cyclic citrullinated peptide (CCP) and rheumatoid factor (RF) in respect of sensitivity, specificity and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec957686ff88cdf33b0252c40b47433d
https://doi.org/10.1515/cclm-2019-0167
https://doi.org/10.1515/cclm-2019-0167
Publikováno v:
World Journal of Emergency Medicine; 2023, Vol. 14 Issue 2, p158-160, 3p
Autor:
Hua HUANG, Han CEN, Li ZHOU, Ting-hui WANG, Wen QIN, Bin-hua XIE, Dong-Mei XIAO, Xiu-Di WU, Hua-Xiang WU
Publikováno v:
Archives of Rheumatology; Dec2019, Vol. 34 Issue 4, p406-413, 8p, 3 Charts
Autor:
Ченева, Александрина1, Иванова, Мария1 Ivanova@mu-varna.bg, Тодорова, Анна1 anna.todorova@mu-varna.bg
Publikováno v:
Management & Education / Upravlenie i Obrazovanie. 2024, Vol. 20 Issue 6, p64-68. 5p.
Publikováno v:
Zhonghua nei ke za zhi. 51(1)
To investigate the clinical efficacy and safety of low-dose rituximab (RTX) for patients in primary Sjögren's syndrome (pSS) with thrombocytopenia.Four pSS patients, 2 with refractory thrombocytopenia and 2 with glucocorticoid-dependent thrombocytop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::03931dd1c1a2c3bbfaad068c5b0b2694
https://pubmed.ncbi.nlm.nih.gov/22490758
https://pubmed.ncbi.nlm.nih.gov/22490758
Autor:
Feng, Huang, Jie, Zhang, Yi, Zheng, Jian-hua, Xu, Xing-fu, Li, Hua-xiang, Wu, Zhi-wei, Chen, Zheng, Zhao, Ya-mei, Zhang
Publikováno v:
Zhonghua nei ke za zhi. 50(12)
To evaluate the efficacy and safety of etanercept 50 mg once-weekly treatment of Chinese patients with active ankylosing spondylitis (AS).Four hundred patients with active AS, enrolled in six medical centers, were randomly divided into either the tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dee8df597e844e24a24fc22a3bf6238e
https://pubmed.ncbi.nlm.nih.gov/22333175
https://pubmed.ncbi.nlm.nih.gov/22333175